2026

Regulatory · Exenatide

Federal Register notice 2026-16998

The Federal Register published notice 2026-16998, attributed to FDA and its parent HHS department, on 2026-08-20. Its official title is “Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

Regulatory · Abaloparatide

Abaloparatide DailyMed SPL version 19

DailyMed lists Structured Product Labeling version 19 for the reviewed Abaloparatide label family with a published date of 2026-08-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Semaglutide

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

PubMed lists PMID 42602345 in Canadian journal of kidney health and disease as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Geographic Disparities in Glucagon Prescriptions Across North Carolina.

PubMed lists PMID 40513916 in American journal of preventive medicine as Journal Article, with publication-date metadata of 2025-06-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

Treatment of obesity with liraglutide in bipolar disorder: a case report.

PubMed lists PMID 42597211 in Frontiers in psychiatry as Case Reports, Journal Article, with publication-date metadata of 2026-07-30 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Inflammation-mediated facial nodules to compounded tirzepatide.

PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07087795

PeptideScanner retained ClinicalTrials.gov record NCT07087795 at 2026-08-13T16:32:13.881Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes.

PubMed lists PMID 39925097 in American journal of physiology. Endocrinology and metabolism as Journal Article, with publication-date metadata of 2025-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

A Computational Glucoregulatory Model of Liver and Glucagon for the Evaluation of Therapeutics.

PubMed lists PMID 40969902 in ACS pharmacology & translational science as Journal Article, with publication-date metadata of 2025-08-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Real-World Indirect Treatment Comparison of Terlipressin vs Midodrine Plus Octreotide in Hepatorenal Syndrome-Acute Kidney Injury.

PubMed lists PMID 41472624 in Clinical and translational gastroenterology as Journal Article, Comparative Study, with publication-date metadata of 2026-02-01 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis.

PubMed lists PMID 41667949 in Molecular medicine (Cambridge, Mass.) as Journal Article, with publication-date metadata of 2026-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols.

PubMed lists PMID 41852535 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis.

PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia Syndrome.

PubMed lists PMID 41945548 in JACC. Case reports as Letter, with publication-date metadata of 2025-12-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to Long Peptide Synthesis: Liraglutide as a Case Study.

PubMed lists PMID 41970854 in ACS omega as Journal Article, with publication-date metadata of 2026-03-25 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.

PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Glucose-dependent dynamics of glucagon, cortisol and adrenocorticotropic hormone before and after gastric bypass.

PubMed lists PMID 41994483 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2026-04-02 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs.

PubMed lists PMID 42022682 in Health science reports as Journal Article, Review, with publication-date metadata of 2026-03-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors.

PubMed lists PMID 42026400 in EJNMMI reports as Journal Article, with publication-date metadata of 2026-04-24 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.

PubMed lists PMID 42058698 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet.

PubMed lists PMID 42076092 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.

PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review.

PubMed lists PMID 42083710 in Cureus as Journal Article, Review, with publication-date metadata of 2026-04-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Facial nodules following filler injections after initiating compounded tirzepatide use.

PubMed lists PMID 42088720 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2026-03-27 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide use for hypothalamic obesity and type 2 diabetes mellitus after suprasellar germinoma treatment.

PubMed lists PMID 42158165 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience.

PubMed lists PMID 42169939 in Journal of gastrointestinal oncology as Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism.

PubMed lists PMID 42232304 in Frontiers in clinical diabetes and healthcare as Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.

PubMed lists PMID 42370133 in Frontiers in oncology as Case Reports, Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based Longitudinal Analysis.

PubMed lists PMID 41734897 in Online journal of public health informatics as Journal Article, with publication-date metadata of 2026-02-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial.

PubMed lists PMID 41771053 in Diabetes care as Letter, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification.

PubMed lists PMID 41810046 in Small science as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China.

PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.

PubMed lists PMID 42592044 in Antibody therapeutics as Journal Article, Review, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug maridebart-cafraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Real-world use of oral semaglutide in adults with type 2 diabetes.

PubMed lists PMID 42592768 in Danish medical journal as Journal Article, Multicenter Study, with publication-date metadata of 2026-06-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Transient teriparatide for postoperative hypocalcaemia with hungry bone features.

PubMed lists PMID 42592840 in European journal of endocrinology as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Role of glucagon in metabolic diseases.

PubMed lists PMID 42593182 in Journal of diabetes investigation as Journal Article, Review, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03883412

PeptideScanner retained ClinicalTrials.gov record NCT03883412 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT05478707

PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07463846

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-08-13T05:54:14.856Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07046819

PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07218354

PeptideScanner retained ClinicalTrials.gov record NCT07218354 at 2026-08-13T05:54:14.857Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07734870

PeptideScanner retained ClinicalTrials.gov record NCT07734870 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

PubMed record PMID 42243958

PeptideScanner retained PubMed bibliographic metadata for PMID 42243958 at 2026-08-12T11:06:05.213Z. PubMed recorded a metadata revision date of 2026-08-12 and an Entrez history date of 2026-06-05. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06077864

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06965413

PeptideScanner retained ClinicalTrials.gov record NCT06965413 at 2026-08-13T05:52:27.007Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06651177

PeptideScanner retained ClinicalTrials.gov record NCT06651177 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Regulatory · Dulaglutide

Dulaglutide DailyMed SPL version 62

DailyMed lists Structured Product Labeling version 62 for the reviewed Dulaglutide label family with a published date of 2026-08-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03884075

PeptideScanner retained ClinicalTrials.gov record NCT03884075 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07754461

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06632444

PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06632457

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 39631560

PeptideScanner retained PubMed bibliographic metadata for PMID 39631560 at 2026-08-10T10:49:06.913Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2024-12-04. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42264960

PeptideScanner retained PubMed bibliographic metadata for PMID 42264960 at 2026-08-10T10:49:10.674Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297751

PeptideScanner retained PubMed bibliographic metadata for PMID 42297751 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297754

PeptideScanner retained PubMed bibliographic metadata for PMID 42297754 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297758

PeptideScanner retained PubMed bibliographic metadata for PMID 42297758 at 2026-08-10T10:49:10.684Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42304199

PeptideScanner retained PubMed bibliographic metadata for PMID 42304199 at 2026-08-10T10:49:10.691Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-16. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42315494

PeptideScanner retained PubMed bibliographic metadata for PMID 42315494 at 2026-08-10T10:49:10.699Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-18. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42348366

PeptideScanner retained PubMed bibliographic metadata for PMID 42348366 at 2026-08-10T10:49:10.723Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-25. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42365987

PeptideScanner retained PubMed bibliographic metadata for PMID 42365987 at 2026-08-10T10:49:10.730Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42387290

PeptideScanner retained PubMed bibliographic metadata for PMID 42387290 at 2026-08-10T10:49:10.738Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-02. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42403263

PeptideScanner retained PubMed bibliographic metadata for PMID 42403263 at 2026-08-10T10:49:10.745Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42420782

PeptideScanner retained PubMed bibliographic metadata for PMID 42420782 at 2026-08-10T10:49:10.753Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42443711

PeptideScanner retained PubMed bibliographic metadata for PMID 42443711 at 2026-08-10T10:49:10.765Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-13. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 30974038

PeptideScanner retained PubMed bibliographic metadata for PMID 30974038 at 2026-08-10T10:49:06.835Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2019-04-12. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38149727

PeptideScanner retained PubMed bibliographic metadata for PMID 38149727 at 2026-08-10T10:49:06.860Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2023-12-27. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38151966

PeptideScanner retained PubMed bibliographic metadata for PMID 38151966 at 2026-08-10T10:49:06.863Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2023-12-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38253809

PeptideScanner retained PubMed bibliographic metadata for PMID 38253809 at 2026-08-10T10:49:06.874Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2024-01-22. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 38302718

PeptideScanner retained PubMed bibliographic metadata for PMID 38302718 at 2026-08-10T10:49:06.877Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2024-02-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 39776038

PeptideScanner retained PubMed bibliographic metadata for PMID 39776038 at 2026-08-10T10:49:06.923Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2025-01-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41342185

PeptideScanner retained PubMed bibliographic metadata for PMID 41342185 at 2026-08-10T10:49:07.015Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2025-12-04. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42557738

PeptideScanner retained PubMed bibliographic metadata for PMID 42557738 at 2026-08-10T10:49:13.006Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42559671

PeptideScanner retained PubMed bibliographic metadata for PMID 42559671 at 2026-08-10T10:49:13.017Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42568245

PeptideScanner retained PubMed bibliographic metadata for PMID 42568245 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42568899

PeptideScanner retained PubMed bibliographic metadata for PMID 42568899 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42569002

PeptideScanner retained PubMed bibliographic metadata for PMID 42569002 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42569707

PeptideScanner retained PubMed bibliographic metadata for PMID 42569707 at 2026-08-10T10:49:13.615Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42570209

PeptideScanner retained PubMed bibliographic metadata for PMID 42570209 at 2026-08-10T10:49:13.625Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT06739122

PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07313761

PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07589686

PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

PubMed record PMID 33491091

PeptideScanner retained PubMed bibliographic metadata for PMID 33491091 at 2026-08-10T10:49:06.839Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2021-01-25. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 38240127

PeptideScanner retained PubMed bibliographic metadata for PMID 38240127 at 2026-08-10T10:49:06.873Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2024-01-19. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41290555

PeptideScanner retained PubMed bibliographic metadata for PMID 41290555 at 2026-08-10T10:49:07.005Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2025-11-25. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41885866

PeptideScanner retained PubMed bibliographic metadata for PMID 41885866 at 2026-08-10T10:49:08.813Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-03-26. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42253285

PeptideScanner retained PubMed bibliographic metadata for PMID 42253285 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42501079

PeptideScanner retained PubMed bibliographic metadata for PMID 42501079 at 2026-08-10T10:49:10.788Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42567173

PeptideScanner retained PubMed bibliographic metadata for PMID 42567173 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42567543

PeptideScanner retained PubMed bibliographic metadata for PMID 42567543 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05093634

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05313529

PeptideScanner retained ClinicalTrials.gov record NCT05313529 at 2026-08-13T05:52:27.020Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07455903

PeptideScanner retained ClinicalTrials.gov record NCT07455903 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

PubMed record PMID 37152965

PeptideScanner retained PubMed bibliographic metadata for PMID 37152965 at 2026-08-10T10:49:06.848Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-05-08. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38082468

PeptideScanner retained PubMed bibliographic metadata for PMID 38082468 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-12-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38093674

PeptideScanner retained PubMed bibliographic metadata for PMID 38093674 at 2026-08-10T10:49:06.858Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-12-14. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38195847

PeptideScanner retained PubMed bibliographic metadata for PMID 38195847 at 2026-08-10T10:49:06.868Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2024-01-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 39604050

PeptideScanner retained PubMed bibliographic metadata for PMID 39604050 at 2026-08-10T10:49:06.908Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2024-11-27. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40429612

PeptideScanner retained PubMed bibliographic metadata for PMID 40429612 at 2026-08-10T10:49:06.946Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-05-28. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40913889

PeptideScanner retained PubMed bibliographic metadata for PMID 40913889 at 2026-08-10T10:49:06.966Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-09-06. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41766347

PeptideScanner retained PubMed bibliographic metadata for PMID 41766347 at 2026-08-10T10:49:08.779Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41804540

PeptideScanner retained PubMed bibliographic metadata for PMID 41804540 at 2026-08-10T10:49:08.787Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41904726

PeptideScanner retained PubMed bibliographic metadata for PMID 41904726 at 2026-08-10T10:49:08.825Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42495930

PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42541373

PeptideScanner retained PubMed bibliographic metadata for PMID 42541373 at 2026-08-10T10:49:12.960Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41321175

PeptideScanner retained PubMed bibliographic metadata for PMID 41321175 at 2026-08-10T10:49:07.012Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-12-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41949681

PeptideScanner retained PubMed bibliographic metadata for PMID 41949681 at 2026-08-10T10:49:08.835Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42026358

PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42542232

PeptideScanner retained PubMed bibliographic metadata for PMID 42542232 at 2026-08-10T10:49:12.963Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42549609

PeptideScanner retained PubMed bibliographic metadata for PMID 42549609 at 2026-08-10T10:49:12.984Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42560020

PeptideScanner retained PubMed bibliographic metadata for PMID 42560020 at 2026-08-10T10:49:13.020Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42560442

PeptideScanner retained PubMed bibliographic metadata for PMID 42560442 at 2026-08-10T10:49:13.020Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38016699

PeptideScanner retained PubMed bibliographic metadata for PMID 38016699 at 2026-08-10T10:49:06.852Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-11-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38073422

PeptideScanner retained PubMed bibliographic metadata for PMID 38073422 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-12-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 38092710

PeptideScanner retained PubMed bibliographic metadata for PMID 38092710 at 2026-08-10T10:49:06.858Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-12-13. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 39618173

PeptideScanner retained PubMed bibliographic metadata for PMID 39618173 at 2026-08-10T10:49:06.912Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2024-12-02. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 40015592

PeptideScanner retained PubMed bibliographic metadata for PMID 40015592 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2025-02-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41532935

PeptideScanner retained PubMed bibliographic metadata for PMID 41532935 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-01-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41802735

PeptideScanner retained PubMed bibliographic metadata for PMID 41802735 at 2026-08-10T10:49:08.786Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42275945

PeptideScanner retained PubMed bibliographic metadata for PMID 42275945 at 2026-08-10T10:49:10.676Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42504064

PeptideScanner retained PubMed bibliographic metadata for PMID 42504064 at 2026-08-10T10:49:10.789Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42552573

PeptideScanner retained PubMed bibliographic metadata for PMID 42552573 at 2026-08-10T10:49:12.986Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42555072

PeptideScanner retained PubMed bibliographic metadata for PMID 42555072 at 2026-08-10T10:49:12.992Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42556854

PeptideScanner retained PubMed bibliographic metadata for PMID 42556854 at 2026-08-10T10:49:12.998Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42556867

PeptideScanner retained PubMed bibliographic metadata for PMID 42556867 at 2026-08-10T10:49:12.998Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42555375

PeptideScanner retained PubMed bibliographic metadata for PMID 42555375 at 2026-08-10T10:49:12.992Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT05663515

PeptideScanner retained ClinicalTrials.gov record NCT05663515 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was exenatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07684235

PeptideScanner retained ClinicalTrials.gov record NCT07684235 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07745504

PeptideScanner retained ClinicalTrials.gov record NCT07745504 at 2026-08-13T05:52:27.004Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 37951584

PeptideScanner retained PubMed bibliographic metadata for PMID 37951584 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2023-11-11. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 38407358

PeptideScanner retained PubMed bibliographic metadata for PMID 38407358 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2024-02-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41651380

PeptideScanner retained PubMed bibliographic metadata for PMID 41651380 at 2026-08-10T10:49:08.761Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-02-06. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41944572

PeptideScanner retained PubMed bibliographic metadata for PMID 41944572 at 2026-08-10T10:49:08.831Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-04-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42549476

PeptideScanner retained PubMed bibliographic metadata for PMID 42549476 at 2026-08-10T10:49:12.984Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 39177865

PeptideScanner retained PubMed bibliographic metadata for PMID 39177865 at 2026-08-10T10:49:06.892Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2024-08-23. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 42251596

PeptideScanner retained PubMed bibliographic metadata for PMID 42251596 at 2026-08-10T10:49:10.669Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-06-07. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 42548796

PeptideScanner retained PubMed bibliographic metadata for PMID 42548796 at 2026-08-10T10:49:12.983Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220759

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06015893

PeptideScanner retained ClinicalTrials.gov record NCT06015893 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 41272927

PeptideScanner retained PubMed bibliographic metadata for PMID 41272927 at 2026-08-10T10:49:06.999Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2025-11-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41736232

PeptideScanner retained PubMed bibliographic metadata for PMID 41736232 at 2026-08-10T10:49:08.773Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-25. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41748193

PeptideScanner retained PubMed bibliographic metadata for PMID 41748193 at 2026-08-10T10:49:08.774Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42012431

PeptideScanner retained PubMed bibliographic metadata for PMID 42012431 at 2026-08-10T10:49:08.852Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42029102

PeptideScanner retained PubMed bibliographic metadata for PMID 42029102 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42258199

PeptideScanner retained PubMed bibliographic metadata for PMID 42258199 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42288971

PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42289805

PeptideScanner retained PubMed bibliographic metadata for PMID 42289805 at 2026-08-10T10:49:10.680Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42333429

PeptideScanner retained PubMed bibliographic metadata for PMID 42333429 at 2026-08-10T10:49:10.713Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-23. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42532234

PeptideScanner retained PubMed bibliographic metadata for PMID 42532234 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42535667

PeptideScanner retained PubMed bibliographic metadata for PMID 42535667 at 2026-08-10T10:49:12.941Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42538551

PeptideScanner retained PubMed bibliographic metadata for PMID 42538551 at 2026-08-10T10:49:12.951Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42538646

PeptideScanner retained PubMed bibliographic metadata for PMID 42538646 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42545022

PeptideScanner retained PubMed bibliographic metadata for PMID 42545022 at 2026-08-10T10:49:12.969Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42546302

PeptideScanner retained PubMed bibliographic metadata for PMID 42546302 at 2026-08-10T10:49:12.978Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42547311

PeptideScanner retained PubMed bibliographic metadata for PMID 42547311 at 2026-08-10T10:49:12.979Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41692643

PeptideScanner retained PubMed bibliographic metadata for PMID 41692643 at 2026-08-10T10:49:08.765Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41812602

PeptideScanner retained PubMed bibliographic metadata for PMID 41812602 at 2026-08-10T10:49:08.791Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41824265

PeptideScanner retained PubMed bibliographic metadata for PMID 41824265 at 2026-08-10T10:49:08.794Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-03-13. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42425925

PeptideScanner retained PubMed bibliographic metadata for PMID 42425925 at 2026-08-10T10:49:10.758Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 33595146

PeptideScanner retained PubMed bibliographic metadata for PMID 33595146 at 2026-08-10T10:49:06.839Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2021-02-17. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40036855

PeptideScanner retained PubMed bibliographic metadata for PMID 40036855 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40510020

PeptideScanner retained PubMed bibliographic metadata for PMID 40510020 at 2026-08-10T10:49:06.950Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-06-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 40978515

PeptideScanner retained PubMed bibliographic metadata for PMID 40978515 at 2026-08-10T10:49:06.968Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-09-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41077767

PeptideScanner retained PubMed bibliographic metadata for PMID 41077767 at 2026-08-10T10:49:06.977Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-10-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42322376

PeptideScanner retained PubMed bibliographic metadata for PMID 42322376 at 2026-08-10T10:49:10.708Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-06-20. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42446801

PeptideScanner retained PubMed bibliographic metadata for PMID 42446801 at 2026-08-10T10:49:10.767Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-14. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42532547

PeptideScanner retained PubMed bibliographic metadata for PMID 42532547 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42533465

PeptideScanner retained PubMed bibliographic metadata for PMID 42533465 at 2026-08-10T10:49:12.933Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 41545261

PeptideScanner retained PubMed bibliographic metadata for PMID 41545261 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-01-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40383978

PeptideScanner retained PubMed bibliographic metadata for PMID 40383978 at 2026-08-10T10:49:06.944Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2025-05-19. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42273973

PeptideScanner retained PubMed bibliographic metadata for PMID 42273973 at 2026-08-10T10:49:10.675Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42437874

PeptideScanner retained PubMed bibliographic metadata for PMID 42437874 at 2026-08-10T10:49:10.764Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42540132

PeptideScanner retained PubMed bibliographic metadata for PMID 42540132 at 2026-08-10T10:49:12.959Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42542297

PeptideScanner retained PubMed bibliographic metadata for PMID 42542297 at 2026-08-10T10:49:12.964Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 40756949

PeptideScanner retained PubMed bibliographic metadata for PMID 40756949 at 2026-08-10T10:49:06.956Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2025-08-04. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42498078

PeptideScanner retained PubMed bibliographic metadata for PMID 42498078 at 2026-08-10T10:49:10.787Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42538728

PeptideScanner retained PubMed bibliographic metadata for PMID 42538728 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Tesamorelin

Tesamorelin DailyMed SPL version 9

DailyMed lists Structured Product Labeling version 9 for the reviewed Tesamorelin label family with a published date of 2026-07-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT06987513

PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

PubMed record PMID 42210124

PeptideScanner retained PubMed bibliographic metadata for PMID 42210124 at 2026-08-10T10:49:10.656Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42515664

PeptideScanner retained PubMed bibliographic metadata for PMID 42515664 at 2026-08-10T10:49:12.892Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42521859

PeptideScanner retained PubMed bibliographic metadata for PMID 42521859 at 2026-08-10T10:49:12.900Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 38323122

PeptideScanner retained PubMed bibliographic metadata for PMID 38323122 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2024-02-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41764752

PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT05882045

PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT05929079

PeptideScanner retained ClinicalTrials.gov record NCT05929079 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05765500

PeptideScanner retained ClinicalTrials.gov record NCT05765500 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

PubMed record PMID 37989596

PeptideScanner retained PubMed bibliographic metadata for PMID 37989596 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2023-11-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41032183

PeptideScanner retained PubMed bibliographic metadata for PMID 41032183 at 2026-08-10T10:49:06.970Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-10-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 41292908

PeptideScanner retained PubMed bibliographic metadata for PMID 41292908 at 2026-08-10T10:49:07.007Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-11-26. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41419187

PeptideScanner retained PubMed bibliographic metadata for PMID 41419187 at 2026-08-10T10:49:08.723Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-19. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41475544

PeptideScanner retained PubMed bibliographic metadata for PMID 41475544 at 2026-08-10T10:49:08.728Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41483046

PeptideScanner retained PubMed bibliographic metadata for PMID 41483046 at 2026-08-10T10:49:08.730Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-01-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41508932

PeptideScanner retained PubMed bibliographic metadata for PMID 41508932 at 2026-08-10T10:49:08.740Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-01-09. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41917519

PeptideScanner retained PubMed bibliographic metadata for PMID 41917519 at 2026-08-10T10:49:08.829Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41999058

PeptideScanner retained PubMed bibliographic metadata for PMID 41999058 at 2026-08-10T10:49:08.848Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-18. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42487213

PeptideScanner retained PubMed bibliographic metadata for PMID 42487213 at 2026-08-10T10:49:10.780Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42513491

PeptideScanner retained PubMed bibliographic metadata for PMID 42513491 at 2026-08-10T10:49:12.876Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42513596

PeptideScanner retained PubMed bibliographic metadata for PMID 42513596 at 2026-08-10T10:49:12.877Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42530904

PeptideScanner retained PubMed bibliographic metadata for PMID 42530904 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42531456

PeptideScanner retained PubMed bibliographic metadata for PMID 42531456 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 39604042

PeptideScanner retained PubMed bibliographic metadata for PMID 39604042 at 2026-07-30T16:31:16.748Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2024-11-27. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41424367

PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42008191

PeptideScanner retained PubMed bibliographic metadata for PMID 42008191 at 2026-08-10T10:49:08.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42321010

PeptideScanner retained PubMed bibliographic metadata for PMID 42321010 at 2026-08-10T10:49:10.706Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-06-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 42419889

PeptideScanner retained PubMed bibliographic metadata for PMID 42419889 at 2026-08-10T10:49:10.753Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42510549

PeptideScanner retained PubMed bibliographic metadata for PMID 42510549 at 2026-08-10T10:49:10.805Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42528856

PeptideScanner retained PubMed bibliographic metadata for PMID 42528856 at 2026-08-10T10:49:12.911Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Glucagon + 5 more

Federal Register notice 2026-15285

The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

Source: Federal Register via GovInfo ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00569127

PeptideScanner retained ClinicalTrials.gov record NCT00569127 at 2026-08-10T18:10:03.946Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT05796388

PeptideScanner retained ClinicalTrials.gov record NCT05796388 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07734792

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Intravenous Glucagon Infusion in the Management of Hypoglycemia in Infants of Diabetic Mothers.

PubMed lists PMID 41610862 in American journal of perinatology as Journal Article, with publication-date metadata of 2026-01-29 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Glutamine Metabolism Supports α cell Mass and Glucagon Secretion.

PubMed lists PMID 42523345 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2026-07-13 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41627802

PeptideScanner retained PubMed bibliographic metadata for PMID 41627802 at 2026-08-10T18:13:40.591Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 41719493

PeptideScanner retained PubMed bibliographic metadata for PMID 41719493 at 2026-08-10T18:13:42.706Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-20. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42219226

PeptideScanner retained PubMed bibliographic metadata for PMID 42219226 at 2026-08-10T18:13:50.707Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-05-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42225300

PeptideScanner retained PubMed bibliographic metadata for PMID 42225300 at 2026-08-10T18:13:50.717Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42361988

PeptideScanner retained PubMed bibliographic metadata for PMID 42361988 at 2026-08-10T18:13:53.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42398904

PeptideScanner retained PubMed bibliographic metadata for PMID 42398904 at 2026-08-10T18:13:53.834Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42493207

PeptideScanner retained PubMed bibliographic metadata for PMID 42493207 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42516799

PeptideScanner retained PubMed bibliographic metadata for PMID 42516799 at 2026-08-10T18:13:56.766Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42516860

PeptideScanner retained PubMed bibliographic metadata for PMID 42516860 at 2026-08-10T18:13:56.767Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42518363

PeptideScanner retained PubMed bibliographic metadata for PMID 42518363 at 2026-08-10T18:13:56.773Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42518535

PeptideScanner retained PubMed bibliographic metadata for PMID 42518535 at 2026-08-10T18:13:56.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42518971

PeptideScanner retained PubMed bibliographic metadata for PMID 42518971 at 2026-08-10T18:13:56.776Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42524366

PeptideScanner retained PubMed bibliographic metadata for PMID 42524366 at 2026-08-10T18:13:56.785Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42526426

PeptideScanner retained PubMed bibliographic metadata for PMID 42526426 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42526939

PeptideScanner retained PubMed bibliographic metadata for PMID 42526939 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42518139

PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42519733

PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42523615

PeptideScanner retained PubMed bibliographic metadata for PMID 42523615 at 2026-08-10T18:13:56.783Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42527705

PeptideScanner retained PubMed bibliographic metadata for PMID 42527705 at 2026-08-10T18:13:57.053Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04484818

PeptideScanner retained ClinicalTrials.gov record NCT04484818 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06169124

PeptideScanner retained ClinicalTrials.gov record NCT06169124 at 2026-08-13T05:56:16.370Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07191873

PeptideScanner retained ClinicalTrials.gov record NCT07191873 at 2026-08-10T18:10:04.225Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07559500

PeptideScanner retained ClinicalTrials.gov record NCT07559500 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07732426

PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

PubMed record PMID 35936066

PeptideScanner retained PubMed bibliographic metadata for PMID 35936066 at 2026-08-10T18:13:32.320Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2022-08-08. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 39655973

PeptideScanner retained PubMed bibliographic metadata for PMID 39655973 at 2026-08-10T18:13:36.057Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2024-12-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41778920

PeptideScanner retained PubMed bibliographic metadata for PMID 41778920 at 2026-08-10T18:13:42.771Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42014432

PeptideScanner retained PubMed bibliographic metadata for PMID 42014432 at 2026-08-10T18:13:48.770Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42516042

PeptideScanner retained PubMed bibliographic metadata for PMID 42516042 at 2026-08-10T18:13:56.764Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42520650

PeptideScanner retained PubMed bibliographic metadata for PMID 42520650 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42521191

PeptideScanner retained PubMed bibliographic metadata for PMID 42521191 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42521631

PeptideScanner retained PubMed bibliographic metadata for PMID 42521631 at 2026-08-10T18:13:56.781Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41712259

PeptideScanner retained PubMed bibliographic metadata for PMID 41712259 at 2026-08-10T18:13:42.694Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41913506

PeptideScanner retained PubMed bibliographic metadata for PMID 41913506 at 2026-08-10T18:13:46.784Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-31. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06072963

PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT06388642

PeptideScanner retained ClinicalTrials.gov record NCT06388642 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Fear of hypoglycemia in parents of children with type 1 diabetes trained for intranasal glucagon use.

PubMed lists PMID 38972099 in Journal of psychosomatic research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41540105

PeptideScanner retained PubMed bibliographic metadata for PMID 41540105 at 2026-08-10T18:13:40.558Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41962807

PeptideScanner retained PubMed bibliographic metadata for PMID 41962807 at 2026-08-10T18:13:46.844Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42314683

PeptideScanner retained PubMed bibliographic metadata for PMID 42314683 at 2026-08-10T18:13:52.286Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-06-18. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42342869

PeptideScanner retained PubMed bibliographic metadata for PMID 42342869 at 2026-08-10T18:13:52.311Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42507607

PeptideScanner retained PubMed bibliographic metadata for PMID 42507607 at 2026-08-10T18:13:56.762Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42507846

PeptideScanner retained PubMed bibliographic metadata for PMID 42507846 at 2026-08-10T18:13:56.762Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42456009

PeptideScanner retained PubMed bibliographic metadata for PMID 42456009 at 2026-08-10T18:13:55.284Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

100 years of glucagon and 100 more.

PubMed lists PMID 37367959 in Diabetologia as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-06-27 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.

PubMed lists PMID 39149351 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2024-08-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Octreotide therapy in patients with a left ventricular assist device and bleeding gastrointestinal angiodysplasias.

PubMed lists PMID 40086695 in The American journal of the medical sciences as Journal Article, with publication-date metadata of 2025-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Titration and discontinuation of semaglutide for weight management in commercially insured US adults.

PubMed lists PMID 40464214 in Obesity (Silver Spring, Md.) as Journal Article, with publication-date metadata of 2025-06-04 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

SSTR-Mediated Precision Delivery: Overcoming Triptolide's Limitations through Octreotide Conjugation in Pancreatic Cancer Treatment.

PubMed lists PMID 40529047 in ACS medicinal chemistry letters as Journal Article, with publication-date metadata of 2025-05-13 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations.

PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.

PubMed lists PMID 41729594 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Ozempic and Wegovy Meet Congress: Political Economy Without Critique and Sociology Without Society.

PubMed lists PMID 41744415 in International journal of social determinants of health and health services as Journal Article, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.

PubMed lists PMID 41780559 in European heart journal as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.

PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Optimization of automated radiosynthesis method for [18F]AlF-NOTA-Octreotide and PET/CT imaging in neuroendocrine neoplasms.

PubMed lists PMID 42014536 in EJNMMI radiopharmacy and chemistry as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Inflammatory Cytokines Impair Glucagon Expression and Secretion in Pancreatic α-Cells.

PubMed lists PMID 42219277 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2026-05-31 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Dysregulated glucagon signaling contributes to hypoglycemia after vertical sleeve gastrectomy in mice.

PubMed lists PMID 42270043 in Molecular metabolism as Journal Article, with publication-date metadata of 2026-06-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial.

PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41364402

PeptideScanner retained PubMed bibliographic metadata for PMID 41364402 at 2026-08-10T18:13:38.016Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2025-12-09. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41686215

PeptideScanner retained PubMed bibliographic metadata for PMID 41686215 at 2026-08-10T18:13:40.663Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-02-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42203210

PeptideScanner retained PubMed bibliographic metadata for PMID 42203210 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-05-27. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42233323

PeptideScanner retained PubMed bibliographic metadata for PMID 42233323 at 2026-08-10T18:13:50.725Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42260100

PeptideScanner retained PubMed bibliographic metadata for PMID 42260100 at 2026-08-10T18:13:52.233Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42286095

PeptideScanner retained PubMed bibliographic metadata for PMID 42286095 at 2026-08-10T18:13:52.266Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42294947

PeptideScanner retained PubMed bibliographic metadata for PMID 42294947 at 2026-08-10T18:13:52.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42307617

PeptideScanner retained PubMed bibliographic metadata for PMID 42307617 at 2026-08-10T18:13:52.282Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42355862

PeptideScanner retained PubMed bibliographic metadata for PMID 42355862 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42355866

PeptideScanner retained PubMed bibliographic metadata for PMID 42355866 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42356253

PeptideScanner retained PubMed bibliographic metadata for PMID 42356253 at 2026-08-10T18:13:53.759Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42394413

PeptideScanner retained PubMed bibliographic metadata for PMID 42394413 at 2026-08-10T18:13:53.810Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42464179

PeptideScanner retained PubMed bibliographic metadata for PMID 42464179 at 2026-08-10T18:13:55.290Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42503373

PeptideScanner retained PubMed bibliographic metadata for PMID 42503373 at 2026-08-10T18:13:56.753Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42503575

PeptideScanner retained PubMed bibliographic metadata for PMID 42503575 at 2026-08-10T18:13:56.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 35611788

PeptideScanner retained PubMed bibliographic metadata for PMID 35611788 at 2026-08-10T18:13:32.311Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2022-05-25. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41894554

PeptideScanner retained PubMed bibliographic metadata for PMID 41894554 at 2026-08-10T18:13:44.905Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-03-27. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42009975

PeptideScanner retained PubMed bibliographic metadata for PMID 42009975 at 2026-08-10T18:13:48.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42171611

PeptideScanner retained PubMed bibliographic metadata for PMID 42171611 at 2026-08-10T18:13:50.652Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-05-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42290292

PeptideScanner retained PubMed bibliographic metadata for PMID 42290292 at 2026-08-10T18:13:52.268Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 22495074

PeptideScanner retained PubMed bibliographic metadata for PMID 22495074 at 2026-08-10T18:13:32.273Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2012-04-13. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Petrelintide

PubMed record PMID 42017294

PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42278509

PeptideScanner retained PubMed bibliographic metadata for PMID 42278509 at 2026-08-10T18:13:52.250Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42278864

PeptideScanner retained PubMed bibliographic metadata for PMID 42278864 at 2026-08-10T18:13:52.251Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42351259

PeptideScanner retained PubMed bibliographic metadata for PMID 42351259 at 2026-08-10T18:13:52.323Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42356491

PeptideScanner retained PubMed bibliographic metadata for PMID 42356491 at 2026-08-10T18:13:53.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42450582

PeptideScanner retained PubMed bibliographic metadata for PMID 42450582 at 2026-08-10T18:13:55.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42500463

PeptideScanner retained PubMed bibliographic metadata for PMID 42500463 at 2026-08-10T18:13:56.748Z. PubMed recorded a metadata revision date of 2026-07-25 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07037433

PeptideScanner retained ClinicalTrials.gov record NCT07037433 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-24, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 42495828

PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42498818

PeptideScanner retained PubMed bibliographic metadata for PMID 42498818 at 2026-08-10T18:13:56.743Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · BPC-157 + 6 more

FDA committee met on seven peptide-related groups of bulk drug substances

FDA convened its Pharmacy Compounding Advisory Committee on July 23-24, 2026, to discuss free-base and acetate bulk drug substances across seven peptide-related groups.

Source: U.S. Food and Drug Administration ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT07496463

PeptideScanner retained ClinicalTrials.gov record NCT07496463 at 2026-08-10T18:10:04.219Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT07723924

PeptideScanner retained ClinicalTrials.gov record NCT07723924 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was plecanatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT07587775

PeptideScanner retained ClinicalTrials.gov record NCT07587775 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

The silent rise of self-prescribed semaglutide use among non-obese young adults in the Middle East.

PubMed lists PMID 42487380 in Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit as Letter, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40521838

PeptideScanner retained PubMed bibliographic metadata for PMID 40521838 at 2026-08-10T18:13:37.865Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2025-06-16. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42491030

PeptideScanner retained PubMed bibliographic metadata for PMID 42491030 at 2026-08-10T18:13:56.726Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38962910

PeptideScanner retained PubMed bibliographic metadata for PMID 38962910 at 2026-08-10T18:13:32.376Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2024-07-04. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41810698

PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42493254

PeptideScanner retained PubMed bibliographic metadata for PMID 42493254 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03796884

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06164795

PeptideScanner retained ClinicalTrials.gov record NCT06164795 at 2026-08-10T18:10:03.919Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07257484

PeptideScanner retained ClinicalTrials.gov record NCT07257484 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Differential Role of Phosphorylation in Glucagon Family Receptor Signaling Revealed by Mass Spectrometry.

PubMed lists PMID 40503712 in Journal of proteome research as Journal Article, with publication-date metadata of 2025-06-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42482900

PeptideScanner retained PubMed bibliographic metadata for PMID 42482900 at 2026-08-10T18:13:56.703Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 42485063

PeptideScanner retained PubMed bibliographic metadata for PMID 42485063 at 2026-08-10T18:13:56.710Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Survodutide

Survodutide liver-activity study record updated

ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06299098

PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06967389

PeptideScanner retained ClinicalTrials.gov record NCT06967389 at 2026-08-10T18:10:03.916Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06975111

PeptideScanner retained ClinicalTrials.gov record NCT06975111 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07715929

PeptideScanner retained ClinicalTrials.gov record NCT07715929 at 2026-08-10T18:10:04.226Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07718126

PeptideScanner retained ClinicalTrials.gov record NCT07718126 at 2026-08-10T18:10:03.957Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line.

PubMed lists PMID 39561351 in Diabetes as Journal Article, with publication-date metadata of 2025-02-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Total Chemical Synthesis of Glucagon Glycoforms Reveals the Remarkable Influence of Natural Glycosylation.

PubMed lists PMID 40337851 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-05-08 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.

PubMed lists PMID 41705736 in Diabetes, obesity & metabolism as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2026-02-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Octreotide in the Management of Chyle Leaks After Head and Neck Surgery: A Systematic Review of Cohort Studies.

PubMed lists PMID 42478204 in The Journal of laryngology and otology as Journal Article, Review, with publication-date metadata of 2026-07-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41160027

PeptideScanner retained PubMed bibliographic metadata for PMID 41160027 at 2026-08-10T18:13:37.970Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42392029

PeptideScanner retained PubMed bibliographic metadata for PMID 42392029 at 2026-08-10T18:13:53.799Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-02. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42479670

PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Maridebart cafraglutide

MariTide bioavailability study record updated

ClinicalTrials.gov lists a completed Maridebart cafraglutide study sponsored by Amgen.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

Mazdutide living-liver-donor study record posted

ClinicalTrials.gov lists a Mazdutide study that is not yet recruiting sponsored by West China Hospital.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06378866

PeptideScanner retained ClinicalTrials.gov record NCT06378866 at 2026-08-10T18:10:04.225Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07707778

PeptideScanner retained ClinicalTrials.gov record NCT07707778 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Comparison between capillary electrophoresis and fluorescence anisotropy competitive immunoassay for glucagon.

PubMed lists PMID 38984929 in Electrophoresis as Journal Article, Comparative Study, with publication-date metadata of 2024-07-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations.

PubMed lists PMID 42474946 in Indian pediatrics as Letter, with publication-date metadata of 2026-07-20 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 42003759

PeptideScanner retained PubMed bibliographic metadata for PMID 42003759 at 2026-08-10T18:13:48.759Z. PubMed recorded a metadata revision date of 2026-07-20 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 39451062

PeptideScanner retained PubMed bibliographic metadata for PMID 39451062 at 2026-08-10T18:13:36.036Z. PubMed recorded a metadata revision date of 2026-07-20 and an Entrez history date of 2024-10-25. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Retatrutide

Retatrutide renal-impairment study record updated

ClinicalTrials.gov lists an active, not recruiting Retatrutide study sponsored by Eli Lilly and Company.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Readability and understandability of online patient education on semaglutide.

PubMed lists PMID 41877445 in Health informatics journal as Journal Article, with publication-date metadata of 2026-03-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression.

PubMed lists PMID 41816810 in Diabetes, obesity & metabolism as Journal Article, Review, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42470452

PeptideScanner retained PubMed bibliographic metadata for PMID 42470452 at 2026-08-10T18:13:56.686Z. PubMed recorded a metadata revision date of 2026-07-18 and an Entrez history date of 2026-07-18. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07602699

PeptideScanner retained ClinicalTrials.gov record NCT07602699 at 2026-08-10T18:10:03.953Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system.

PubMed lists PMID 42166306 in Journal of managed care & specialty pharmacy as Journal Article, Observational Study, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Influence of Social Media on Self-Medication Behavior: A Study on Ozempic Use Among Emirati University Students.

PubMed lists PMID 42196730 in International journal of environmental research and public health as Journal Article, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.

PubMed lists PMID 42469146 in Nutrition, metabolism, and cardiovascular diseases : NMCD as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42001280

PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42219795

PeptideScanner retained PubMed bibliographic metadata for PMID 42219795 at 2026-08-10T18:13:50.715Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-06-01. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42465095

PeptideScanner retained PubMed bibliographic metadata for PMID 42465095 at 2026-08-10T18:13:55.292Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Cagrilintide

Cagrilintide pediatric study record updated

ClinicalTrials.gov lists a recruiting Cagrilintide study sponsored by Novo Nordisk A/S.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06814938

PeptideScanner retained ClinicalTrials.gov record NCT06814938 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT06817356

PeptideScanner retained ClinicalTrials.gov record NCT06817356 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Redefining peptide therapeutics with semaglutide.

PubMed lists PMID 38321235 in Nature chemistry as Journal Article, with publication-date metadata of 2024-02 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

PubMed lists PMID 42082865 in Journal of endocrinological investigation as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, with publication-date metadata of 2026-05-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Identification of insulin and glucagon genes in the finless porpoise and the developmental distribution of their producing endocrine cells.

PubMed lists PMID 42147104 in Frontiers in endocrinology as Journal Article, with publication-date metadata of 2026-04-30 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.

PubMed lists PMID 42462869 in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery as Editorial, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42083746

PeptideScanner retained PubMed bibliographic metadata for PMID 42083746 at 2026-08-10T18:13:48.845Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42084774

PeptideScanner retained PubMed bibliographic metadata for PMID 42084774 at 2026-08-10T18:13:48.846Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42128272

PeptideScanner retained PubMed bibliographic metadata for PMID 42128272 at 2026-08-10T18:13:50.589Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT06596135

PeptideScanner retained ClinicalTrials.gov record NCT06596135 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06934642

PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions.

PubMed lists PMID 41966799 in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

GLP-1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids.

PubMed lists PMID 41983366 in Diabetes, obesity & metabolism as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2026-04-15 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

PubMed lists PMID 42133304 in JAMA as Journal Article, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

Development of zein-based nanoparticles for oral co-delivery of insulin and liraglutide and preliminary in vivo evaluation in Danio rerio.

PubMed lists PMID 42442575 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2026-07-13 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 41988866

PeptideScanner retained PubMed bibliographic metadata for PMID 41988866 at 2026-08-10T18:13:46.880Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 41997403

PeptideScanner retained PubMed bibliographic metadata for PMID 41997403 at 2026-08-10T18:13:46.888Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42041438

PeptideScanner retained PubMed bibliographic metadata for PMID 42041438 at 2026-08-10T18:13:48.795Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Liraglutide

Liraglutide DailyMed SPL version 6

DailyMed lists Structured Product Labeling version 6 for the reviewed Liraglutide label family with a published date of 2026-07-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Semaglutide

Semaglutide treatment for children with obesity: an observational study.

PubMed lists PMID 38471743 in Archives of disease in childhood as Journal Article, Observational Study, with publication-date metadata of 2024-09-25 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

A case of multiple type I endocrine neoplasia with gastrin-producing and glucagon-producing tumors successfully resected 18 years after insulinoma surgery.

PubMed lists PMID 41945253 in Clinical journal of gastroenterology as Journal Article, Case Reports, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: Research Summary.

PubMed lists PMID 42133336 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026.

PubMed lists PMID 42313535 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate.

PubMed lists PMID 42445014 in ACS medicinal chemistry letters as Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

A simple mechanistic model for insulin-glucose-glucagon dynamics and its implications for diabetes management.

PubMed lists PMID 42448581 in Mathematical biosciences and engineering : MBE as Journal Article, with publication-date metadata of 2026-05-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41931341

PeptideScanner retained PubMed bibliographic metadata for PMID 41931341 at 2026-08-10T18:13:46.810Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-03. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41933740

PeptideScanner retained PubMed bibliographic metadata for PMID 41933740 at 2026-08-10T18:13:46.811Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-04. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42339090

PeptideScanner retained PubMed bibliographic metadata for PMID 42339090 at 2026-08-10T18:13:52.307Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42448476

PeptideScanner retained PubMed bibliographic metadata for PMID 42448476 at 2026-08-10T18:13:55.255Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-07-14. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 41604554

PeptideScanner retained PubMed bibliographic metadata for PMID 41604554 at 2026-08-10T18:13:40.573Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41945630

PeptideScanner retained PubMed bibliographic metadata for PMID 41945630 at 2026-08-10T18:13:46.825Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-07. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05896293

PeptideScanner retained ClinicalTrials.gov record NCT05896293 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT07531251

PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery.

PubMed lists PMID 39719890 in Journal of biomedical materials research. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.

PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis.

PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41865922

PeptideScanner retained PubMed bibliographic metadata for PMID 41865922 at 2026-08-10T18:13:44.869Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-03-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41593376

PeptideScanner retained PubMed bibliographic metadata for PMID 41593376 at 2026-08-10T18:13:40.572Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-01-27. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 41898733

PeptideScanner retained PubMed bibliographic metadata for PMID 41898733 at 2026-08-10T18:13:46.758Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42443448

PeptideScanner retained PubMed bibliographic metadata for PMID 42443448 at 2026-08-10T18:13:55.249Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-07-13. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Elamipretide

Elamipretide Barth syndrome study record updated

ClinicalTrials.gov lists a recruiting Elamipretide study sponsored by Stealth BioTherapeutics Inc.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

PubMed lists PMID 38717708 in PharmacoEconomics as Journal Article, with publication-date metadata of 2024-05-08 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Latent phosphaturic mesenchymal tumor in left planta detected by [18F]F-AlF-NOTA-octreotide PET/CT.

PubMed lists PMID 38568449 in European journal of nuclear medicine and molecular imaging as Case Reports, Journal Article, with publication-date metadata of 2024-04-03 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Comprehensive design and characterization of pH-gradient-loaded donkey-milk exosomes for oral octreotide delivery: A bench-to-in silico roadmap.

PubMed lists PMID 41831704 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in patients with hidradenitis suppurativa and obesity.

PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

Recurrent ventricular asystole during octreotide infusion in a patient with pancreatic neuroendocrine tumor: a case report.

PubMed lists PMID 41840662 in Journal of medical case reports as Journal Article, Case Reports, with publication-date metadata of 2026-03-16 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

In vivo dysregulation of insulin and glucagon secretion: Disturbed mitochonderial VDAC1 expression and localization in pancreatic β-cells convey global insulin secretory defects in diabetic GK rat.

PubMed lists PMID 42402267 in Biochimica et biophysica acta. Molecular basis of disease as Journal Article, with publication-date metadata of 2026-07-05 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.

PubMed lists PMID 42436546 in Molecular brain as Journal Article, with publication-date metadata of 2026-07-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 41022243

PeptideScanner retained PubMed bibliographic metadata for PMID 41022243 at 2026-08-10T18:13:37.942Z. PubMed recorded a metadata revision date of 2026-07-11 and an Entrez history date of 2025-09-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05498272

PeptideScanner retained ClinicalTrials.gov record NCT05498272 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT07417631

PeptideScanner retained ClinicalTrials.gov record NCT07417631 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was dulaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.

PubMed lists PMID 41772149 in Nature medicine as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II, with publication-date metadata of 2026-03-02 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41764620

PeptideScanner retained PubMed bibliographic metadata for PMID 41764620 at 2026-08-10T18:13:42.760Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41801306

PeptideScanner retained PubMed bibliographic metadata for PMID 41801306 at 2026-08-10T18:13:44.801Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 32213649

PeptideScanner retained PubMed bibliographic metadata for PMID 32213649 at 2026-08-10T18:13:32.288Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2020-03-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41802484

PeptideScanner retained PubMed bibliographic metadata for PMID 41802484 at 2026-08-10T18:13:44.802Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41811086

PeptideScanner retained PubMed bibliographic metadata for PMID 41811086 at 2026-08-10T18:13:44.817Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Glucagon

Glucagon DailyMed SPL version 2

DailyMed lists Structured Product Labeling version 2 for the reviewed Glucagon label family with a published date of 2026-07-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02319837

PeptideScanner retained ClinicalTrials.gov record NCT02319837 at 2026-08-10T18:10:03.933Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04775082

PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06727331

PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07693608

PeptideScanner retained ClinicalTrials.gov record NCT07693608 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

PubMed record PMID 38237649

PeptideScanner retained PubMed bibliographic metadata for PMID 38237649 at 2026-08-10T18:13:32.340Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2024-01-18. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41762856

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42418774

PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42425580

PeptideScanner retained PubMed bibliographic metadata for PMID 42425580 at 2026-08-10T18:13:55.212Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Safety · Glucagon

FDA enforcement report D-0723-2026

FDA's dated enforcement report D-0723-2026 lists Class II and source status Ongoing for Lupin Pharmaceuticals Inc. PeptideScanner connects the report to reviewed application ANDA214457 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Regulatory · Insulin glargine-aldy

Insulin glargine-aldy DailyMed SPL version 5

DailyMed lists Structured Product Labeling version 5 for the reviewed Insulin glargine-aldy label family with a published date of 2026-07-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05616013

PeptideScanner retained ClinicalTrials.gov record NCT05616013 at 2026-08-10T18:10:03.915Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06935838

PeptideScanner retained ClinicalTrials.gov record NCT06935838 at 2026-08-10T18:10:03.949Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

PubMed record PMID 41706383

PeptideScanner retained PubMed bibliographic metadata for PMID 41706383 at 2026-08-10T18:13:42.683Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-18. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41710402

PeptideScanner retained PubMed bibliographic metadata for PMID 41710402 at 2026-08-10T18:13:42.691Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41732124

PeptideScanner retained PubMed bibliographic metadata for PMID 41732124 at 2026-08-10T18:13:42.721Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-24. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41714054

PeptideScanner retained PubMed bibliographic metadata for PMID 41714054 at 2026-08-10T18:13:42.699Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

Clinical Pharmacology of Glucagon.

PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05569772

PeptideScanner retained ClinicalTrials.gov record NCT05569772 at 2026-08-10T18:10:03.935Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06893211

PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Liraglutide and systolic blood pressure.

PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41654147

PeptideScanner retained PubMed bibliographic metadata for PMID 41654147 at 2026-08-10T18:13:40.626Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-02-07. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42415111

PeptideScanner retained PubMed bibliographic metadata for PMID 42415111 at 2026-08-10T18:13:53.859Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-07-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 39789749

PeptideScanner retained PubMed bibliographic metadata for PMID 39789749 at 2026-08-10T18:13:36.068Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Petrelintide

Petrelintide combination study record posted

ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche.

Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Leuprolide DailyMed SPL version 10

DailyMed lists Structured Product Labeling version 10 for the reviewed Leuprolide label family with a published date of 2026-07-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07682818

PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice.

PubMed lists PMID 38247052 in The Annals of pharmacotherapy as Review, Letter, with publication-date metadata of 2024-01-21 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review.

PubMed lists PMID 42388932 in Cureus as Published Erratum, Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41621839

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42205046

PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 37743669

PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

PubMed lists PMID 37967247 in The Journal of clinical endocrinology and metabolism as Randomized Controlled Trial, Journal Article, with publication-date metadata of 2024-04-19 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 41174925

PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Glucagon

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, with publication-date metadata of 2026-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 38567654

PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05371496

PeptideScanner retained ClinicalTrials.gov record NCT05371496 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07037459

PeptideScanner retained ClinicalTrials.gov record NCT07037459 at 2026-08-10T18:10:04.222Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?

PubMed lists PMID 39018899 in Journal of diabetes and its complications as Editorial, with publication-date metadata of 2024-07-15 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 38649657

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38870730

PeptideScanner retained PubMed bibliographic metadata for PMID 38870730 at 2026-08-10T18:13:32.367Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA212972

The official Drugs@FDA dataset lists original submission 1 for ANDA 212972 with status AP dated 2026-07-01, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.

PubMed lists PMID 16441980 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Octreotide

[Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].

PubMed lists PMID 17922063 in Magyar onkologia as Journal Article, with publication-date metadata of 2007-10-07 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in Schizophrenia-A Top Clinical Trial.

PubMed lists PMID 42384388 in JAMA psychiatry as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Teriparatide

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption.

PubMed lists PMID 41604908 in Biomaterials advances as Journal Article, with publication-date metadata of 2026-01-14 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38602181

PeptideScanner retained PubMed bibliographic metadata for PMID 38602181 at 2026-07-30T16:11:44.832Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 39370607

PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41596703

PeptideScanner retained PubMed bibliographic metadata for PMID 41596703 at 2026-07-30T16:11:44.884Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41597428

PeptideScanner retained PubMed bibliographic metadata for PMID 41597428 at 2026-07-30T16:11:44.888Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41610120

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41579168

PeptideScanner retained PubMed bibliographic metadata for PMID 41579168 at 2026-07-30T16:11:44.866Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-24. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42385164

PeptideScanner retained PubMed bibliographic metadata for PMID 42385164 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42385677

PeptideScanner retained PubMed bibliographic metadata for PMID 42385677 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07671248

PeptideScanner retained ClinicalTrials.gov record NCT07671248 at 2026-07-30T16:38:53.229Z. Its registry update date was 2026-07-01, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Exenatide DailyMed SPL version 17

DailyMed lists Structured Product Labeling version 17 for the reviewed Exenatide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Semaglutide

Semaglutide DailyMed SPL version 19

DailyMed lists Structured Product Labeling version 19 for the reviewed Semaglutide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Teriparatide

Teriparatide DailyMed SPL version 9

DailyMed lists Structured Product Labeling version 9 for the reviewed Teriparatide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Liraglutide

Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study.

PubMed lists PMID 39949066 in Annals of clinical and translational neurology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-02-13 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39305160

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220642

PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.

PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.

PubMed lists PMID 42086873 in Pharmaceutical research as Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it.

PubMed lists PMID 42373101 in BMJ (Clinical research ed.) as Journal Article, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42245779

PeptideScanner retained PubMed bibliographic metadata for PMID 42245779 at 2026-07-30T16:14:18.092Z. PubMed recorded a metadata revision date of 2026-06-29 and an Entrez history date of 2026-06-05. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04822181

PeptideScanner retained ClinicalTrials.gov record NCT04822181 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

Octreotide and Octreotide-derived delivery systems.

PubMed lists PMID 37211679 in Journal of drug targeting as Journal Article, Review, with publication-date metadata of 2023-05-23 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Glucagon

An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC).

PubMed lists PMID 37678603 in Molecular and cellular endocrinology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-09-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis.

PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Secondary alopecia due to semaglutide.

PubMed lists PMID 42364353 in Medicina clinica as Letter, with publication-date metadata of 2026-06-27 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

A comprehensive analysis of community pharmacists' practices, barriers, and strategies in patient education on Saxenda®: a qualitative study.

PubMed lists PMID 42015323 in Journal of pharmaceutical health care and sciences as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38688894

PeptideScanner retained PubMed bibliographic metadata for PMID 38688894 at 2026-07-30T16:14:06.935Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41612464

PeptideScanner retained PubMed bibliographic metadata for PMID 41612464 at 2026-07-30T16:14:14.832Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41680431

PeptideScanner retained PubMed bibliographic metadata for PMID 41680431 at 2026-07-30T16:14:14.846Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-02-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 41880072

PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42033613

PeptideScanner retained PubMed bibliographic metadata for PMID 42033613 at 2026-07-30T16:14:16.695Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-04-25. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Liraglutide + 2 more

Federal Register notice 2026-12937

The Federal Register published notice 2026-12937, attributed to FDA and its parent HHS department, on 2026-06-26. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide, Semaglutide and Tirzepatide.

Source: Federal Register via GovInfo ↗

Literature metadata · Semaglutide

Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration.

PubMed lists PMID 40850442 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Semaglutide

Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States.

PubMed lists PMID 41524543 in Expert review of pharmacoeconomics & outcomes research as Journal Article, Observational Study, with publication-date metadata of 2026-01-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

PubMed lists PMID 41256163 in medRxiv : the preprint server for health sciences as Journal Article, Preprint, with publication-date metadata of 2025-10-05 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

PubMed lists PMID 42151574 in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine as Published Erratum, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38533633

PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 40789979

PeptideScanner retained PubMed bibliographic metadata for PMID 40789979 at 2026-07-30T16:14:11.079Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-08-11. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41023931

PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41520850

PeptideScanner retained PubMed bibliographic metadata for PMID 41520850 at 2026-07-30T16:14:14.728Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41539984

PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 41547183

PeptideScanner retained PubMed bibliographic metadata for PMID 41547183 at 2026-07-30T16:14:14.777Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04777409

PeptideScanner retained ClinicalTrials.gov record NCT04777409 at 2026-07-30T16:19:03.047Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07592546

PeptideScanner retained ClinicalTrials.gov record NCT07592546 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists.

PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 39919773

PeptideScanner retained PubMed bibliographic metadata for PMID 39919773 at 2026-07-30T16:14:10.828Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-02-07. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41500837

PeptideScanner retained PubMed bibliographic metadata for PMID 41500837 at 2026-07-30T16:14:13.067Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41506099

PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42330995

PeptideScanner retained PubMed bibliographic metadata for PMID 42330995 at 2026-07-30T16:14:19.343Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Cagrilintide

PubMed record PMID 39868309

PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Cagrilintide

PubMed record PMID 42260118

PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07505303

PeptideScanner retained ClinicalTrials.gov record NCT07505303 at 2026-07-30T16:19:03.067Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07668414

PeptideScanner retained ClinicalTrials.gov record NCT07668414 at 2026-07-30T16:19:03.061Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03070886

PeptideScanner retained ClinicalTrials.gov record NCT03070886 at 2026-07-30T16:19:03.056Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 39527338

PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07158021

PeptideScanner retained ClinicalTrials.gov record NCT07158021 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-23, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Residual gastric content after tirzepatide discontinuation: is one week enough?

PubMed lists PMID 42329593 in Minerva anestesiologica as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38954432

PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40035775

PeptideScanner retained PubMed bibliographic metadata for PMID 40035775 at 2026-07-30T16:14:10.913Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40072017

PeptideScanner retained PubMed bibliographic metadata for PMID 40072017 at 2026-07-30T16:14:10.926Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42329358

PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 40246242

PeptideScanner retained PubMed bibliographic metadata for PMID 40246242 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42324588

PeptideScanner retained PubMed bibliographic metadata for PMID 42324588 at 2026-07-30T16:14:19.320Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2026-06-21. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 39718468

PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38600796

PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 40890141

PeptideScanner retained PubMed bibliographic metadata for PMID 40890141 at 2026-07-30T16:14:11.108Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2025-09-01. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38715179

PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38685598

PeptideScanner retained PubMed bibliographic metadata for PMID 38685598 at 2026-07-30T16:14:06.932Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04423211

PeptideScanner retained ClinicalTrials.gov record NCT04423211 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07441252

PeptideScanner retained ClinicalTrials.gov record NCT07441252 at 2026-07-30T16:19:03.063Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07657676

PeptideScanner retained ClinicalTrials.gov record NCT07657676 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.

PubMed lists PMID 38757729 in Diabetes, obesity & metabolism as Journal Article, Clinical Trial, with publication-date metadata of 2024-05-17 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 40570323

PeptideScanner retained PubMed bibliographic metadata for PMID 40570323 at 2026-07-30T16:14:11.030Z. PubMed recorded a metadata revision date of 2026-06-17 and an Entrez history date of 2025-06-26. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05669664

PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07650240

PeptideScanner retained ClinicalTrials.gov record NCT07650240 at 2026-07-30T16:19:03.043Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07654062

PeptideScanner retained ClinicalTrials.gov record NCT07654062 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Leuprolide

Development and Validation of a Stability-Indicating RS HPLC Method for Leuprolide Acetate and Its Related Substances: Characterization of Degradation Products With LC-MS.

PubMed lists PMID 42299119 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2026-07 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38869953

PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05726227

PeptideScanner retained ClinicalTrials.gov record NCT05726227 at 2026-07-30T16:19:03.202Z. Its registry update date was 2026-06-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07027124

PeptideScanner retained ClinicalTrials.gov record NCT07027124 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA213155

The official Drugs@FDA dataset lists original submission 1 for ANDA 213155 with status AP dated 2026-06-15, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Literature metadata · Ziconotide

PubMed record PMID 41910723

PeptideScanner retained PubMed bibliographic metadata for PMID 41910723 at 2026-07-30T16:14:16.607Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-03-30. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42290373

PeptideScanner retained PubMed bibliographic metadata for PMID 42290373 at 2026-07-30T16:14:18.165Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42291734

PeptideScanner retained PubMed bibliographic metadata for PMID 42291734 at 2026-07-30T16:14:19.224Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05605964

PeptideScanner retained ClinicalTrials.gov record NCT05605964 at 2026-07-30T16:19:03.061Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Epitalon

PubMed record PMID 40493162

PeptideScanner retained PubMed bibliographic metadata for PMID 40493162 at 2026-07-30T16:14:11.014Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2025-06-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42070740

PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42082001

PeptideScanner retained PubMed bibliographic metadata for PMID 42082001 at 2026-07-30T16:14:16.712Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-04. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42142418

PeptideScanner retained PubMed bibliographic metadata for PMID 42142418 at 2026-07-30T16:14:16.748Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-16. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 42239562

PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00329043

PeptideScanner retained ClinicalTrials.gov record NCT00329043 at 2026-07-30T16:19:03.050Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07226765

PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07225686

PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07382024

PeptideScanner retained ClinicalTrials.gov record NCT07382024 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06864026

PeptideScanner retained ClinicalTrials.gov record NCT06864026 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

PubMed lists PMID 41311271 in Tissue engineering. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 39805462

PeptideScanner retained PubMed bibliographic metadata for PMID 39805462 at 2026-07-30T16:14:08.923Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2025-01-13. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42266945

PeptideScanner retained PubMed bibliographic metadata for PMID 42266945 at 2026-07-30T16:14:18.139Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2026-06-10. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06305598

PeptideScanner retained ClinicalTrials.gov record NCT06305598 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07282769

PeptideScanner retained ClinicalTrials.gov record NCT07282769 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07462663

PeptideScanner retained ClinicalTrials.gov record NCT07462663 at 2026-07-30T16:19:03.043Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

PubMed record PMID 39933708

PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 40099812

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40246631

PeptideScanner retained PubMed bibliographic metadata for PMID 40246631 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42264536

PeptideScanner retained PubMed bibliographic metadata for PMID 42264536 at 2026-07-30T16:14:18.135Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 34561620

PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41866701

PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04467983

PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 39740666

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Tirzepatide

Early cardiovascular-kidney-metabolic progression with tirzepatide: population definition and clinical interpretation.

PubMed lists PMID 42155604 in Diabetes research and clinical practice as Letter, with publication-date metadata of 2026-05-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Regulatory · Insulin glargine-aldy

Insulin glargine-aldy DailyMed SPL version 2

DailyMed lists Structured Product Labeling version 2 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Linaclotide

PubMed record PMID 41413756

PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06976853

PeptideScanner retained ClinicalTrials.gov record NCT06976853 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07218445

PeptideScanner retained ClinicalTrials.gov record NCT07218445 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07630454

PeptideScanner retained ClinicalTrials.gov record NCT07630454 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04167163

PeptideScanner retained ClinicalTrials.gov record NCT04167163 at 2026-07-30T16:19:03.051Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.

PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 39109464

PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42228044

PeptideScanner retained PubMed bibliographic metadata for PMID 42228044 at 2026-07-30T16:14:18.046Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-02. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42238253

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05424003

PeptideScanner retained ClinicalTrials.gov record NCT05424003 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07228741

PeptideScanner retained ClinicalTrials.gov record NCT07228741 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07627074

PeptideScanner retained ClinicalTrials.gov record NCT07627074 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT.

PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39864410

PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07204249

PeptideScanner retained ClinicalTrials.gov record NCT07204249 at 2026-07-30T16:19:03.057Z. Its registry update date was 2026-06-03, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Insulin glargine-aldy

Insulin glargine-aldy DailyMed SPL version 1

DailyMed lists Structured Product Labeling version 1 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · MOTS-c

PubMed record PMID 42153537

PeptideScanner retained PubMed bibliographic metadata for PMID 42153537 at 2026-07-30T16:14:16.751Z. PubMed recorded a metadata revision date of 2026-06-02 and an Entrez history date of 2026-05-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06571383

PeptideScanner retained ClinicalTrials.gov record NCT06571383 at 2026-07-30T16:19:03.050Z. Its registry update date was 2026-06-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Linaclotide

Linaclotide DailyMed SPL version 39

DailyMed lists Structured Product Labeling version 39 for the reviewed Linaclotide label family with a published date of 2026-06-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Liraglutide

Current status of Liraglutide delivery systems for the management of type 2 diabetes mellitus.

PubMed lists PMID 40914786 in Drug delivery and translational research as Journal Article, Review, with publication-date metadata of 2025-09-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Understanding Weight Regain After Tirzepatide Withdrawal.

PubMed lists PMID 42043833 in JAMA internal medicine as Journal Article, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38990651

PeptideScanner retained PubMed bibliographic metadata for PMID 38990651 at 2026-07-30T16:14:08.785Z. PubMed recorded a metadata revision date of 2026-06-01 and an Entrez history date of 2024-07-11. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38877681

PeptideScanner retained PubMed bibliographic metadata for PMID 38877681 at 2026-07-30T16:20:38.897Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-06-15. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 39407425

PeptideScanner retained PubMed bibliographic metadata for PMID 39407425 at 2026-07-30T16:20:39.038Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-10-16. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Safety · Semaglutide + 1 more

FDA details concerns with unapproved GLP-1 products

FDA's public page describes agency concerns and actions involving unapproved versions of semaglutide and tirzepatide, with adverse-event information dated May 31, 2026.

Source: U.S. Food and Drug Administration ↗

Literature metadata · Exenatide

PubMed record PMID 42175654

PeptideScanner retained PubMed bibliographic metadata for PMID 42175654 at 2026-07-30T16:20:45.825Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-23. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42217255

PeptideScanner retained PubMed bibliographic metadata for PMID 42217255 at 2026-07-30T16:20:46.631Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-30. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42198317

PeptideScanner retained PubMed bibliographic metadata for PMID 42198317 at 2026-07-30T16:20:45.939Z. PubMed recorded a metadata revision date of 2026-05-29 and an Entrez history date of 2026-05-27. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07610174

PeptideScanner retained ClinicalTrials.gov record NCT07610174 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05774756

PeptideScanner retained ClinicalTrials.gov record NCT05774756 at 2026-07-30T16:19:36.905Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Can Intermittent Teriparatide Facilitate Supraphysiological-Rate Distraction Osteogenesis? A Feasibility Study in the Rabbit Tibial Lengthening Model.

PubMed lists PMID 40657227 in Indian journal of orthopaedics as Journal Article, with publication-date metadata of 2025-05-27 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 42127399

PeptideScanner retained PubMed bibliographic metadata for PMID 42127399 at 2026-07-30T16:20:45.678Z. PubMed recorded a metadata revision date of 2026-05-28 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06485089

PeptideScanner retained ClinicalTrials.gov record NCT06485089 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Safety · Liraglutide

FDA enforcement report D-0541-2026

FDA's dated enforcement report D-0541-2026 lists Class II and source status Ongoing for Lupin Pharmaceuticals Inc. PeptideScanner connects the report to reviewed application ANDA215421 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07469800

PeptideScanner retained ClinicalTrials.gov record NCT07469800 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04126070

PeptideScanner retained ClinicalTrials.gov record NCT04126070 at 2026-07-30T16:19:36.912Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05333003

PeptideScanner retained ClinicalTrials.gov record NCT05333003 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

PubMed record PMID 42189020

PeptideScanner retained PubMed bibliographic metadata for PMID 42189020 at 2026-07-30T16:20:45.877Z. PubMed recorded a metadata revision date of 2026-05-26 and an Entrez history date of 2026-05-26. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 39043357

PeptideScanner retained PubMed bibliographic metadata for PMID 39043357 at 2026-07-30T16:20:38.933Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2024-07-23. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 39793696

PeptideScanner retained PubMed bibliographic metadata for PMID 39793696 at 2026-07-30T16:20:39.143Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Semaglutide

Semaglutide DailyMed SPL version 18

DailyMed lists Structured Product Labeling version 18 for the reviewed Semaglutide label family with a published date of 2026-05-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Vosoritide

PubMed record PMID 42043535

PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 41056349

PeptideScanner retained PubMed bibliographic metadata for PMID 41056349 at 2026-07-30T16:20:41.592Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2025-10-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07605247

PeptideScanner retained ClinicalTrials.gov record NCT07605247 at 2026-07-30T16:19:36.902Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02860923

PeptideScanner retained ClinicalTrials.gov record NCT02860923 at 2026-07-30T16:19:36.924Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was exenatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT06373731

PeptideScanner retained ClinicalTrials.gov record NCT06373731 at 2026-07-30T16:19:36.914Z. Its registry update date was 2026-05-20, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs.

PubMed lists PMID 38619705 in Drug delivery and translational research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-15 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 41240216

PeptideScanner retained PubMed bibliographic metadata for PMID 41240216 at 2026-07-30T16:20:41.667Z. PubMed recorded a metadata revision date of 2026-05-20 and an Entrez history date of 2025-11-15. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39289684

PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 39574155

PeptideScanner retained PubMed bibliographic metadata for PMID 39574155 at 2026-07-30T16:20:39.074Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-11-22. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04469855

PeptideScanner retained ClinicalTrials.gov record NCT04469855 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01293292

PeptideScanner retained ClinicalTrials.gov record NCT01293292 at 2026-07-30T16:19:36.921Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT06554717

PeptideScanner retained ClinicalTrials.gov record NCT06554717 at 2026-07-30T16:19:36.918Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).

PubMed lists PMID 26044820 in BMC musculoskeletal disorders as Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-06-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide in Children and Adolescents with Type 2 Diabetes.

PubMed lists PMID 31034184 in The New England journal of medicine as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-04-28 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 33137293

PeptideScanner retained PubMed bibliographic metadata for PMID 33137293 at 2026-07-30T16:20:34.542Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2020-11-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 37268435

PeptideScanner retained PubMed bibliographic metadata for PMID 37268435 at 2026-07-30T16:20:36.524Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-06-02. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 38071418

PeptideScanner retained PubMed bibliographic metadata for PMID 38071418 at 2026-07-30T16:20:36.586Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-12-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 39244617

PeptideScanner retained PubMed bibliographic metadata for PMID 39244617 at 2026-07-30T16:20:38.998Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2024-09-07. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 39605874

PeptideScanner retained PubMed bibliographic metadata for PMID 39605874 at 2026-07-30T16:20:39.082Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2024-11-28. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 22564709

PeptideScanner retained PubMed bibliographic metadata for PMID 22564709 at 2026-07-30T16:20:34.419Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2012-05-09. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 25331030

PeptideScanner retained PubMed bibliographic metadata for PMID 25331030 at 2026-07-30T16:20:34.456Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2014-10-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT05989711

PeptideScanner retained ClinicalTrials.gov record NCT05989711 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was pemvidutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06041217

PeptideScanner retained ClinicalTrials.gov record NCT06041217 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Pemvidutide

Pemvidutide IMPACT study record updated

ClinicalTrials.gov lists a completed Pemvidutide study sponsored by Altimmune, Inc.

Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.

PubMed lists PMID 39491674 in Journal of pharmaceutical sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-02 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives.

PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38159221

PeptideScanner retained PubMed bibliographic metadata for PMID 38159221 at 2026-07-30T16:20:36.597Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2023-12-30. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42123221

PeptideScanner retained PubMed bibliographic metadata for PMID 42123221 at 2026-07-30T16:20:45.661Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00544830

PeptideScanner retained ClinicalTrials.gov record NCT00544830 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07557953

PeptideScanner retained ClinicalTrials.gov record NCT07557953 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT05652205

PeptideScanner retained ClinicalTrials.gov record NCT05652205 at 2026-07-30T16:19:36.913Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT05151484

PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07523633

PeptideScanner retained ClinicalTrials.gov record NCT07523633 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT03770338

PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Safety · Octreotide

FDA enforcement report D-0519-2026

FDA's dated enforcement report D-0519-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Regulatory · Afamelanotide

Afamelanotide DailyMed SPL version 11

DailyMed lists Structured Product Labeling version 11 for the reviewed Afamelanotide label family with a published date of 2026-05-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Dulaglutide

PubMed record PMID 38871561

PeptideScanner retained PubMed bibliographic metadata for PMID 38871561 at 2026-07-30T16:20:38.896Z. PubMed recorded a metadata revision date of 2026-05-13 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01155232

PeptideScanner retained ClinicalTrials.gov record NCT01155232 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05586802

PeptideScanner retained ClinicalTrials.gov record NCT05586802 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07059377

PeptideScanner retained ClinicalTrials.gov record NCT07059377 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06734273

PeptideScanner retained ClinicalTrials.gov record NCT06734273 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 38719260

PeptideScanner retained PubMed bibliographic metadata for PMID 38719260 at 2026-07-30T16:20:36.695Z. PubMed recorded a metadata revision date of 2026-05-07 and an Entrez history date of 2024-05-08. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Tirzepatide

Tirzepatide DailyMed SPL version 38

DailyMed lists Structured Product Labeling version 38 for the reviewed Tirzepatide label family with a published date of 2026-05-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07298915

PeptideScanner retained ClinicalTrials.gov record NCT07298915 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 42083939

PeptideScanner retained PubMed bibliographic metadata for PMID 42083939 at 2026-07-30T16:20:43.803Z. PubMed recorded a metadata revision date of 2026-05-05 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 40536052

PeptideScanner retained PubMed bibliographic metadata for PMID 40536052 at 2026-07-30T16:20:41.387Z. PubMed recorded a metadata revision date of 2026-05-04 and an Entrez history date of 2025-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04019197

PeptideScanner retained ClinicalTrials.gov record NCT04019197 at 2026-07-30T16:19:36.918Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07443956

PeptideScanner retained ClinicalTrials.gov record NCT07443956 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07554638

PeptideScanner retained ClinicalTrials.gov record NCT07554638 at 2026-07-30T16:19:36.907Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 42068058

PeptideScanner retained PubMed bibliographic metadata for PMID 42068058 at 2026-07-30T16:20:43.725Z. PubMed recorded a metadata revision date of 2026-05-02 and an Entrez history date of 2026-05-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Glucagon + 3 more

Federal Register notice 2026-08552

The Federal Register published notice 2026-08552, attributed to FDA and its parent HHS department, on 2026-05-01. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide and Tirzepatide.

Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04194554

PeptideScanner retained ClinicalTrials.gov record NCT04194554 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02944500

PeptideScanner retained ClinicalTrials.gov record NCT02944500 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03856632

PeptideScanner retained ClinicalTrials.gov record NCT03856632 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Federal Register notice 2026-08435

The Federal Register published notice 2026-08435, attributed to FDA and its parent HHS department, on 2026-04-30. Its official title is “Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Source: Federal Register via GovInfo ↗

Literature metadata · Lanreotide

Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.

PubMed lists PMID 38206830 in The oncologist as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-05-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06176365

PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06309992

PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide + 2 more

FDA proposes excluding three GLP-1 ingredients from the 503B bulks list

FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk substances that 503B outsourcing facilities may use for compounding.

Source: U.S. Food and Drug Administration ↗

Regulatory · Insulin glargine-aldy

Drugs@FDA application BLA761412

The official Drugs@FDA dataset lists original submission 1 for BLA 761412 with status AP dated 2026-04-29, and names insulin glargine-aldy among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04174755

PeptideScanner retained ClinicalTrials.gov record NCT04174755 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT05500586

PeptideScanner retained ClinicalTrials.gov record NCT05500586 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was glucagon.

Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03841058

PeptideScanner retained ClinicalTrials.gov record NCT03841058 at 2026-07-30T16:20:49.320Z. Its registry update date was 2026-04-28, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07065552

PeptideScanner retained ClinicalTrials.gov record NCT07065552 at 2026-07-30T16:20:49.313Z. Its registry update date was 2026-04-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD.

PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Tirzepatide

Real world tirzepatide treatment for fatty liver disease.

PubMed lists PMID 41776028 in Hepatology international as Editorial, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41959165

PeptideScanner retained PubMed bibliographic metadata for PMID 41959165 at 2026-07-30T16:22:18.487Z. PubMed recorded a metadata revision date of 2026-04-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 41960633

PeptideScanner retained PubMed bibliographic metadata for PMID 41960633 at 2026-07-30T16:22:18.490Z. PubMed recorded a metadata revision date of 2026-04-24 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05646706

PeptideScanner retained ClinicalTrials.gov record NCT05646706 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-23, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Setmelanotide

Federal Register rule 2026-07863

The Federal Register published rule 2026-07863, attributed to FDA and its parent HHS department, on 2026-04-22. Its official title is “Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06283667

PeptideScanner retained ClinicalTrials.gov record NCT06283667 at 2026-07-30T16:20:49.310Z. Its registry update date was 2026-04-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT06124807

PeptideScanner retained ClinicalTrials.gov record NCT06124807 at 2026-07-30T16:20:49.321Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was mazdutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41157964

PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05746039

PeptideScanner retained ClinicalTrials.gov record NCT05746039 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06424106

PeptideScanner retained ClinicalTrials.gov record NCT06424106 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was glucagon.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06657209

PeptideScanner retained ClinicalTrials.gov record NCT06657209 at 2026-07-30T16:20:49.310Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT05482789

PeptideScanner retained ClinicalTrials.gov record NCT05482789 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was exenatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 38987029

PeptideScanner retained PubMed bibliographic metadata for PMID 38987029 at 2026-07-30T16:22:12.162Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-07-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 39284294

PeptideScanner retained PubMed bibliographic metadata for PMID 39284294 at 2026-07-30T16:22:15.952Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-09-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41401696

PeptideScanner retained PubMed bibliographic metadata for PMID 41401696 at 2026-07-30T16:22:18.312Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2025-12-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41994885

PeptideScanner retained PubMed bibliographic metadata for PMID 41994885 at 2026-07-30T16:22:19.404Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06558188

PeptideScanner retained ClinicalTrials.gov record NCT06558188 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-17, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Regulatory · BPC-157 + 6 more

Federal Register notice 2026-07361

The Federal Register published notice 2026-07361, attributed to FDA and its parent HHS department, on 2026-04-16. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List,” and PeptideScanner's exact reviewed identity mapping connects the document to BPC-157, Emideltide, Epitalon, KPV, MOTS-c, Semax and TB-500.

Source: Federal Register via GovInfo ↗

Safety · Lanreotide

FDA enforcement report D-0422-2026

FDA's dated enforcement report D-0422-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Safety · Lanreotide

FDA enforcement report D-0423-2026

FDA's dated enforcement report D-0423-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application ANDA217193 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06811324

PeptideScanner retained ClinicalTrials.gov record NCT06811324 at 2026-07-30T16:20:49.320Z. Its registry update date was 2026-04-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02772588

PeptideScanner retained ClinicalTrials.gov record NCT02772588 at 2026-07-30T16:20:49.312Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02960022

PeptideScanner retained ClinicalTrials.gov record NCT02960022 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06751589

PeptideScanner retained ClinicalTrials.gov record NCT06751589 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41967490

PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41123247

PeptideScanner retained PubMed bibliographic metadata for PMID 41123247 at 2026-07-30T16:22:16.181Z. PubMed recorded a metadata revision date of 2026-04-10 and an Entrez history date of 2025-10-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT05048901

PeptideScanner retained ClinicalTrials.gov record NCT05048901 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was lanreotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT02127437

PeptideScanner retained ClinicalTrials.gov record NCT02127437 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was lanreotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07338214

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

Literature metadata · Tesamorelin

PubMed record PMID 34006921

PeptideScanner retained PubMed bibliographic metadata for PMID 34006921 at 2026-07-30T16:22:11.959Z. PubMed recorded a metadata revision date of 2026-04-07 and an Entrez history date of 2021-05-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 33858329

PeptideScanner retained PubMed bibliographic metadata for PMID 33858329 at 2026-07-30T16:22:11.958Z. PubMed recorded a metadata revision date of 2026-04-06 and an Entrez history date of 2021-04-16. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06604624

PeptideScanner retained ClinicalTrials.gov record NCT06604624 at 2026-07-30T16:20:49.309Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41615893

PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03119584

PeptideScanner retained ClinicalTrials.gov record NCT03119584 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Semaglutide DailyMed SPL version 17

DailyMed lists Structured Product Labeling version 17 for the reviewed Semaglutide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Setmelanotide

Setmelanotide DailyMed SPL version 14

DailyMed lists Structured Product Labeling version 14 for the reviewed Setmelanotide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Safety · Octreotide

FDA enforcement report D-0404-2026

FDA's dated enforcement report D-0404-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Safety · Octreotide

FDA enforcement report D-0405-2026

FDA's dated enforcement report D-0405-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Safety · Octreotide

FDA enforcement report D-0406-2026

FDA's dated enforcement report D-0406-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Source: FDA enforcement reports via openFDA ↗

Literature metadata · Tesamorelin

PubMed record PMID 38905488

PeptideScanner retained PubMed bibliographic metadata for PMID 38905488 at 2026-07-30T16:22:12.148Z. PubMed recorded a metadata revision date of 2026-04-01 and an Entrez history date of 2024-06-21. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06264609

PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06734130

PeptideScanner retained ClinicalTrials.gov record NCT06734130 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT07126262

PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT06807437

PeptideScanner retained ClinicalTrials.gov record NCT06807437 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was lanreotide.

Source: ClinicalTrials.gov ↗

Regulatory · Retatrutide + 1 more

FDA warning letter names retatrutide and tirzepatide products

FDA issued a warning letter to Gram Peptides that describes the agency's findings about products marketed with retatrutide and tirzepatide.

Source: U.S. Food and Drug Administration ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02817659

PeptideScanner retained ClinicalTrials.gov record NCT02817659 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.

Source: ClinicalTrials.gov ↗

Clinical trials · Ziconotide

ClinicalTrials.gov record NCT07499882

PeptideScanner retained ClinicalTrials.gov record NCT07499882 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was ziconotide.

Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA212552

The official Drugs@FDA dataset lists original submission 1 for ANDA 212552 with status AP dated 2026-03-30, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Literature metadata · BPC-157

PubMed record PMID 41901308

PeptideScanner retained PubMed bibliographic metadata for PMID 41901308 at 2026-07-30T16:23:42.486Z. PubMed recorded a metadata revision date of 2026-03-30 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 41901218

PeptideScanner retained PubMed bibliographic metadata for PMID 41901218 at 2026-07-30T16:23:42.462Z. PubMed recorded a metadata revision date of 2026-03-30 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 37178114

PeptideScanner retained PubMed bibliographic metadata for PMID 37178114 at 2026-07-30T16:23:33.798Z. PubMed recorded a metadata revision date of 2026-03-27 and an Entrez history date of 2023-05-13. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05933499

PeptideScanner retained ClinicalTrials.gov record NCT05933499 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06118203

PeptideScanner retained ClinicalTrials.gov record NCT06118203 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

PubMed record PMID 40423516

PeptideScanner retained PubMed bibliographic metadata for PMID 40423516 at 2026-07-30T16:23:36.824Z. PubMed recorded a metadata revision date of 2026-03-26 and an Entrez history date of 2025-05-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Dulaglutide

Dulaglutide DailyMed SPL version 60

DailyMed lists Structured Product Labeling version 60 for the reviewed Dulaglutide label family with a published date of 2026-03-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Lanreotide

Lanreotide in endothelial corneal inflammation.

PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07220473

PeptideScanner retained ClinicalTrials.gov record NCT07220473 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-24, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT06662539

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

Clinical trials · TB-500

ClinicalTrials.gov record NCT07487363

PeptideScanner retained ClinicalTrials.gov record NCT07487363 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was tb-500.

Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

PubMed record PMID 39157869

PeptideScanner retained PubMed bibliographic metadata for PMID 39157869 at 2026-07-30T16:23:36.341Z. PubMed recorded a metadata revision date of 2026-03-23 and an Entrez history date of 2024-08-19. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Lixisenatide

Lixisenatide DailyMed SPL version 25

DailyMed lists Structured Product Labeling version 25 for the reviewed Lixisenatide label family with a published date of 2026-03-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT07009860

PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07227948

PeptideScanner retained ClinicalTrials.gov record NCT07227948 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT07481734

PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

FDA announces approval of a higher-dose semaglutide product

FDA announced approval of a higher-dose Wegovy product, adding a regulatory event to the semaglutide profile's selected official records.

Source: U.S. Food and Drug Administration ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT04219007

PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06934655

PeptideScanner retained ClinicalTrials.gov record NCT06934655 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06989177

PeptideScanner retained ClinicalTrials.gov record NCT06989177 at 2026-07-30T16:22:22.331Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06989203

PeptideScanner retained ClinicalTrials.gov record NCT06989203 at 2026-07-30T16:22:22.329Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT02724228

PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT04554940

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT02572323

PeptideScanner retained ClinicalTrials.gov record NCT02572323 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07468552

PeptideScanner retained ClinicalTrials.gov record NCT07468552 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06252493

PeptideScanner retained ClinicalTrials.gov record NCT06252493 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was glucagon.

Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA215245

The official Drugs@FDA dataset lists original submission 1 for ANDA 215245 with status AP dated 2026-03-11, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07213466

PeptideScanner retained ClinicalTrials.gov record NCT07213466 at 2026-07-30T16:22:22.332Z. Its registry update date was 2026-03-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT05845749

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT07460908

PeptideScanner retained ClinicalTrials.gov record NCT07460908 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Federal Register notice 2026-04546

The Federal Register published notice 2026-04546, attributed to FDA and its parent HHS department, on 2026-03-09. Its official title is “Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

Literature metadata · Abaloparatide

PubMed record PMID 41798079

PeptideScanner retained PubMed bibliographic metadata for PMID 41798079 at 2026-07-30T16:23:41.290Z. PubMed recorded a metadata revision date of 2026-03-09 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06330805

PeptideScanner retained ClinicalTrials.gov record NCT06330805 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Literature metadata · Retatrutide

PubMed record PMID 40735804

PeptideScanner retained PubMed bibliographic metadata for PMID 40735804 at 2026-07-30T16:23:38.757Z. PubMed recorded a metadata revision date of 2026-03-07 and an Entrez history date of 2025-07-30. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 41793078

PeptideScanner retained PubMed bibliographic metadata for PMID 41793078 at 2026-07-30T16:23:41.287Z. PubMed recorded a metadata revision date of 2026-03-07 and an Entrez history date of 2026-03-07. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 38634774

PeptideScanner retained PubMed bibliographic metadata for PMID 38634774 at 2026-07-30T16:23:36.263Z. PubMed recorded a metadata revision date of 2026-03-06 and an Entrez history date of 2024-04-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 38736212

PeptideScanner retained PubMed bibliographic metadata for PMID 38736212 at 2026-07-30T16:23:36.274Z. PubMed recorded a metadata revision date of 2026-03-06 and an Entrez history date of 2024-05-13. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00936390

PeptideScanner retained ClinicalTrials.gov record NCT00936390 at 2026-07-30T16:22:22.345Z. Its registry update date was 2026-03-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05965908

PeptideScanner retained ClinicalTrials.gov record NCT05965908 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-06, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Semaglutide DailyMed SPL version 16

DailyMed lists Structured Product Labeling version 16 for the reviewed Semaglutide label family with a published date of 2026-03-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Vosoritide

PubMed record PMID 41783511

PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

PubMed record PMID 41337722

PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

PubMed record PMID 41337723

PeptideScanner retained PubMed bibliographic metadata for PMID 41337723 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05681299

PeptideScanner retained ClinicalTrials.gov record NCT05681299 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-04, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

Regulatory · Tirzepatide

Tirzepatide DailyMed SPL version 37

DailyMed lists Structured Product Labeling version 37 for the reviewed Tirzepatide label family with a published date of 2026-03-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Literature metadata · Dulaglutide

PubMed record PMID 41231281

PeptideScanner retained PubMed bibliographic metadata for PMID 41231281 at 2026-07-30T16:23:39.111Z. PubMed recorded a metadata revision date of 2026-03-03 and an Entrez history date of 2025-11-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT03946527

PeptideScanner retained ClinicalTrials.gov record NCT03946527 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was lanreotide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05700903

PeptideScanner retained ClinicalTrials.gov record NCT05700903 at 2026-07-30T16:22:22.343Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Regulatory · Octreotide + 1 more

Federal Register notice 2026-03963

The Federal Register published notice 2026-03963, attributed to FDA and its parent HHS department, on 2026-02-27. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide and Semaglutide.

Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06027567

PeptideScanner retained ClinicalTrials.gov record NCT06027567 at 2026-07-30T16:23:45.644Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06759701

PeptideScanner retained ClinicalTrials.gov record NCT06759701 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07095517

PeptideScanner retained ClinicalTrials.gov record NCT07095517 at 2026-07-30T16:23:45.642Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Clinical trials · BPC-157

BPC-157 hamstring study appears in trial registry

ClinicalTrials.gov lists a recruiting BPC-157 study sponsored by Hudson Biotech.

Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Liraglutide DailyMed SPL version 3

DailyMed lists Structured Product Labeling version 3 for the reviewed Liraglutide label family with a published date of 2026-02-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Tirzepatide

Tirzepatide DailyMed SPL version 36

DailyMed lists Structured Product Labeling version 36 for the reviewed Tirzepatide label family with a published date of 2026-02-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA217063

The official Drugs@FDA dataset lists original submission 1 for ANDA 217063 with status AP dated 2026-02-24, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA217234

The official Drugs@FDA dataset lists original submission 1 for ANDA 217234 with status AP dated 2026-02-24, and names liraglutide among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05891496

PeptideScanner retained ClinicalTrials.gov record NCT05891496 at 2026-07-30T16:23:45.669Z. Its registry update date was 2026-02-24, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01786265

PeptideScanner retained ClinicalTrials.gov record NCT01786265 at 2026-07-30T16:23:45.644Z. Its registry update date was 2026-02-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07423247

PeptideScanner retained ClinicalTrials.gov record NCT07423247 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 40903014

PeptideScanner retained PubMed bibliographic metadata for PMID 40903014 at 2026-07-30T16:25:12.584Z. PubMed recorded a metadata revision date of 2026-02-19 and an Entrez history date of 2025-09-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 41693775

PeptideScanner retained PubMed bibliographic metadata for PMID 41693775 at 2026-07-30T16:25:14.309Z. PubMed recorded a metadata revision date of 2026-02-18 and an Entrez history date of 2026-02-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 39252648

PeptideScanner retained PubMed bibliographic metadata for PMID 39252648 at 2026-07-30T16:25:12.445Z. PubMed recorded a metadata revision date of 2026-02-17 and an Entrez history date of 2024-09-10. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata · Survodutide

PubMed record PMID 41388343

PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Regulatory · Semaglutide

Semaglutide DailyMed SPL version 15

DailyMed lists Structured Product Labeling version 15 for the reviewed Semaglutide label family with a published date of 2026-02-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

Source: DailyMed · U.S. National Library of Medicine ↗

Regulatory · Semaglutide

Federal Register notice 2026-02786

The Federal Register published notice 2026-02786, attributed to FDA and its parent HHS department, on 2026-02-12. Its official title is “Jeremy Spencer Brown: Final Debarment Order,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05320406

PeptideScanner retained ClinicalTrials.gov record NCT05320406 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide